Lithium, but not carbamazepine, potentiates hyperactivity induced by intra-accumbens cholera toxin

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 1, 1998, Pages 191-200

  Kofman, Ora ^a   Li, Peter P ^a   Warsh, Jerry J ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Bipolar affective disorder; Carbamazepine; Cholera toxin; G protein; Lithium; Locomotor activity nucleus accumbens

Indexed keywords

CARBAMAZEPINE; CHOLERA TOXIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LITHIUM;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPULSION; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENTIATION; HUMAN; HYPERACTIVITY; INTRACEREBRAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NEUROMODULATION; NUCLEUS ACCUMBENS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADENOSINE DIPHOSPHATE RIBOSE; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; CARBAMAZEPINE; CATALYSIS; CHOLERA TOXIN; DRUG SYNERGISM; GTP-BINDING PROTEINS; HYPERKINESIS; LITHIUM; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; TRIXIS;

EID: 0031973757     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00410-3     Document Type: Article

References (57)

1. Avissar S., Schreiber G., Danon A., Belmaker R. H. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature. 331:1988;440-442.
2. Avissar S., Schreiber G., Aulakh C. S., Murphy D. L. Carbamazepine and electroconvulsive shock attenuate β-adrenergic and muscarinic receptor coupling to G proteins in rat cortex. J. Pharmacol. (Mol. Pharmacol.). 189:1990;99-103.
3. Avissar S., Schreiber G. The involvement of guanine-nucleotide binding proteins in the pathogenesis and treatment of affective disorders. Biol. Psychiatry. 31:1992;435-459.
4. Bloom F. E., Baetge G., Deyo S., Ettenberg A., Koda L., Magistretti P. J., Shoemaker W. J., Staunton D. A. Chemical and physiological aspects of the actions of lithium and antidepressant drugs. Neuropharmacology. 22:1983;359-365.
5. 2 autoreceptors in chick sympathetic neurons. J. Neurochem. 66:1996;1019-1026.
6. Bradford M. M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-252.
7. Byrnes J. J., Weinstein D. M., Uretsky N. J., Wallace L. J. Micro-injection of cholera toxin into the ventral tegmental area produces enhanced locomotor responses to subsequent amphetamine administration. Soc. Neurosci. Abstr. 21:1995;971.
8. Carli M., Anand-Srivastava M. B., Molina-Holgado E., Dewar K. M., Reader T. A. Effects of chronic lithium treatments on central dopaminergic receptors systems. G proteins as possible targets Neurochem. Int. 24:1994;13-22.
9. Chang F.-H., Bourne H. R. Cholera toxin induces cAMP independent degradation of Gs. J. Biol. Chem. 264:1989;5352-5357.
10. Chen G., Manji H. K., Wright C. B., Hawver D. B., Potter W. Z. Effects of valproic acid on β-adrenergic receptors, G proteins, and adenylyl cyclase in rat C6 glioma cells. Neuropsychopharmacology. 15:1996;271-280.
11. Chen G., Pan B, Hawver D. B., Wright C. B., Potter W. Z., Manji H. K. Attenuation of cyclic AMP production by carbamazepine. J. Neurochem. 67:1996;2079-2086.
12. Chen J., Rasenick M. M. Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase. J. Neurochem. 64:1995;724-732.
13. Clifton P. J., Somerville E. M. Disturbance of meal patterning following nucleus accumbens lesions in the rat. Brain Res. 667:1994;123-128.
14. Colin S. F., Chang H. C., Mollner S., Pfeuffer T., Reed R. R., Duman R. S., Nestler E. J. Chronic lithium regulates the expression of adenylate cyclase and Gi-protein α subunit in rat cerebral cortex. Proc. Natl. Acad. Sci. USA. 88:1991;10634-10637.
15. Cowburn R. F., Marcusson J. O., Eriksson A., Wiehager B., O'Neill C. Adenylyl cyclase activity and G protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res. 623:1994;297-304.
16. Cunningham S. T., Kelley A. E. Hyperactivity and sensitization to psychostimulants following cholera infusion into the nucleus accumbens. J. Neurosci. 13:1993;2342-2350.
17. Ebstein R. P., Hermoni M., Belmaker R. H. The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain. Inhibition after chronic treatment and absence of supersensitivity J. Pharmacol. Exp. Ther. 213:1980;161-167.
18. Friedman E., Wang H.-Y. Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. J. Neurochem. 64:1996;1145-1152.
19. Hamburger-Bar R., Robert M., Newman M., Belmaker R. H. Interstrain correlation between behavioral effects of lithium and effects on cortical cyclic AMP. Pharmacol. Biochem. Behav. 24:1986;9-13.
20. Hsiao J. K., Manji H. K., Chen G., Bitran J. A., Risby E. D., Potter W. Z. Lithium administration modulates platelet Gi in humans. Life Sci. 50:1992;227-233.
21. Iyo M., Maeda Y., Inada T, Kitao Y., Sasaki H., Fukui S. The effects of a selective cAMP phosphodiesterase inhibitor, rolipram, on methamphetamine-induced behavior. Neuropsychopharmacology. 18:1995;33-39.
22. Kelley A. E., Finn M., Cunningham S. T., Renshaw P., Sachs G. Lithium diet enhances the behavioural response to cholera toxin infusion into the nucleus accumbens. Soc. Neurosci. Abstr. 19:1993;130.15.
23. Kelley A. E., Holahan M., Finn M. Cholera toxin infusion into nucleus accumbens. Interactions with motor activity, dopamine agonists and conditioned reinforcement Soc. Neurosci. Abstr. 21:1995;168.
24. 2 receptors in striatum couple to Ni regulatory protein and inhibition of cyclic AMP accumulation. Naunyn Schmiedebergs Arch. Pharmacol. 335:1987;618-623.
25. Kofman O., Belmaker R. H. Biochemical, behavioural and clinical studies of the role of inositol in lithium treatment and depression. Biol. Psychiatry. 34:1993;839-852.
26. Kots A. Y., Gumanova N. G., Akhmedzhanov N. M., Varentsov S. I., Gerasimova C. I., Bulargina T. V., Shakhov Y. A. The GTP-binding regulatory proteins, Gs and Gi are altered in erythrocyte membranes of patients with ischemic heart disease resulting from coronary atherosclerosis. Arterioscler. Thromb. 13:1993;1244-1251.
27. 3H] spiroperidol binding sites Brain Res. 267:1983;301-311.
28. 2 mRNA abundance in rat cerebral cortex. Eur. J. Pharmacol. (Mol. Pharmacol.). 207:1991;355-359.
29. Li P. P., Sibony D., Green M. A., Warsh J. J. Lithium modulation of phosphoinositide signaling system in rat cortex. Selective effect on phorbol ester binding J. Neurochem. 61:1993;1722-1730.
30. Li P. P., Young T., Tam Y. K., Sibony D., Warsh J. J. Effects of chronic lithium and carbamazepine treatment on G-protein subunit expression in rat cerebral cortex. Biol. Psychiatry. 34:1993;162-170.
31. Manji H. K., Chen G., Shimon H., Hsiao J. K., Potter W. Z., Belmaker R. H. Guanine nucleotide-binding proteins in bipolar affective disorder - Effects of long term lithium treatment. Arch. Gen. Psychiatry. 52:1995;135-144.
32. Manji H. K., Potter W. Z., Lenox R. H. Signal transduction pathways. Molecular targets for lithium's actions. Arch. Gen. Psychiatry. 52:1995;531-543.
33. Masana M. I., Bitran J. A., Hsiao J. K., Potter W. Z. In vivo evidence that lithium inactivates Gi modulation of adenylate cyclase activity in brain. J. Neurochem. 59:1992;200-205.
34. Miller R. J., Kelly P. H. Dopamine-like effects of cholera toxin in the central nervous system. Nature. 255:1975;163-166.
35. Miserenido M. J. D., Nestler E. J. Behavioral sensitization to cocaine. Modulation by the cyclic AMP system in the nucleus accumbens Brain Res. 674:1995;299-306.
36. Mørk A., Geisler A. Mode of action of lithium on the catalytic unit of adenylate cyclase from rat brain. Pharmacol. Toxicol. 60:1987;241-248.
37. Mørk A., Geisler A. Effects of GTP on hormone-stimulated adenylate cyclase activity in cerebral cortex, striatum and hippocampus from rats treated chronically with lithium. Biol. Psychiatry. 26:1989;279-288.
38. Newman M. E., Belmaker R. H. Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the rat. Neuropharmacology. 26:1987;211-217.
39. Newman M. E., Ben-Zeev A., Lerer B. Chloramphetamine did not prevent the effects of chronic antidepressants on 5-hydroxytryptamine inhibition of forskolin-stimulated adenylate cyclase in rat hippocampus. Eur. J. Pharmacol. 207:1991;209-213.
40. Ozawa H., Rasenick M. M. Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment. Mol. Pharmacol. 36:1989;803-808.
41. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, Orlando FL.
42. Pittman K. J., Jakubovic A., Fibiger H. C. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat. Psychopharmacology (Berlin). 82:1984;371-377.
43. Post R. M., Weiss S. R., Pert A. Differential effects of carbamazepine and lithium on sensitization and kindling. Prog. Neuropharmacol. Biol. Psychiatry. 8:1984;425-434.
44. Risby E. D., Hsiao J. K., Manji H. K., Bitran J., Moses F., Zhou D. F., Potter W. Z. The mechanism of action of lithium, II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects Arch. Gen. Psychiatry. 48:1991;513-524.
45. Sampson M., Ruddel M., Elin R. J. Lithium determinations evaluated in eight analyzers. Clin. Chem. 40:1994;869-872.
46. Schreiber G., Avissar S., Danon A., Belmaker R. H. Hyperfunctional G proteins in mononuclear leukocytes of patients with mania. Biol. Psychiatry. 29:1991;273-280.
47. Skolnick J., Daly J. Norepinephrine-sensitive adenylate cyclases in rat brains. Relation to behavior and tyrosine hydroxylase Science. 184:1974;174-176.
48. Smith D. E. Effects of lithium and rolipram enantiomers on locomotor activity in inbred mice. Pharmacol. Toxicol. 66:1990;142-145.
49. Soldin S. J. Anticonvulsants. Wong S. H. Y. Therapeutic drug monitoring and toxicology by liquid chromatography. 1985;351-365 Marcel Dekker, New York.
50. Staunton D. A., Magistretti P. J., Shoemaker W. J., Bloom F. E. Effects of chronic lithium treatment on dopamine receptors in the corpus striatum II. No effect on denervation or neuroleptic-induced supersensitivity. Brain Res. 232:1982;401-412.
51. Swerdlow N. R., Lee D., Koob G. F., Vaccarino F. J. Effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat. J. Pharmacol. Exp. Ther. 236:1985;324-329.
52. Tamir A., Gill D. M. ADP-ribosylation by cholera toxin of membrane protein. J. Neurochem. 50:1988;1791-1797.
53. Wachtel H. Neurotropic effects of the optical isomers of the selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitor rolipram in rats in vivo. J. Pharm. Pharmacol. 35:1982;440-444.
54. Wang, H. Y.; Friedman, E.: Lithium interferes with coupling of serotonin receptors to their G proteins. ECNP Abstr. 317; 1994.
55. Williams M. B., Li X., Gu X., Jope R. S. Modulation of endogenous ADP-ribosylation in rat brain. Brain Res. 592:1992;49-56.
56. Young L. T., Li P. P., Kish S. J., Siu K. P., Kamble A., Hornykiewicz O., Warsh J. J. Cerebral cortex Gsα protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J. Neurochem. 61:1993;890-898.
57. Young L. T., Li P. P., Kamble A., Siu K. P., Warsh J. J. Mononuclear leukocyte levels of G proteins in depressed patients with bipolar affective disorder. Am. J. Psychiatry. 151:1994;594-596.